Aardvark Therapeutics Inc. Common Stock (AARD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Aardvark Therapeutics Inc...

NASDAQ: AARD · Real-Time Price · USD
16.20
0.12 (0.75%)
At close: Oct 06, 2025, 11:21 AM

Aardvark Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
61.64M 9.73M 15.56M
Short-Term Investments
12.02M 254K 546K
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
2.63M 13K 14K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
160K 127K 70K
Total Current Assets
74.14M 10.37M 16.49M
Property-Plant & Equipment
735K 155K 252K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
3.37M 168K 266K
Total Assets
77.51M 10.54M 16.76M
Account Payables
2.3M 1.03M 259K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
338K 112K 100K
Other Current Liabilities
558K -67K -47K
Total Current Liabilities
4.93M 1.38M 595K
Long-Term Debt
n/a 43.9M 43.9M
Other Long-Term Liabilities
26K 2K 19K
Total Long-Term Liabilities
127.22M 43.96M 44.09M
Total Liabilities
132.15M 45.34M 44.68M
Total Debt
779K 162K 262K
Book Value
-54.64M -34.8M -27.92M
Book Value Per Share
-4.23 -2.7 -2.87
Common Stock
n/a n/a n/a
Retained Earnings
-58.33M -37.74M -30.53M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
-54.64M -34.8M -27.92M
Total Investments
12.02M 254K 546K